Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer

被引:34
|
作者
Pastille, Eva [1 ]
Fassnacht, Tabea [1 ]
Adamczyk, Alexandra [1 ]
Nhi Ngo Thi Phuong [1 ]
Buer, Jan [1 ]
Westendorf, Astrid M. [1 ]
机构
[1] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
关键词
Toll-like receptor 4; colitis-associated colon cancer; inflammation; TAK-242; intestinal immune cells; COLORECTAL-CANCER; GUT MICROBIOTA; TOLL; RECEPTOR-4; RISK;
D O I
10.3389/fimmu.2021.669747
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Patients suffering from ulcerative colitis are at increased risk of developing colorectal cancer. Although the exact underlying mechanisms of inflammation-associated carcinogenesis remain unknown, the intestinal microbiota as well as pathogenic bacteria are discussed as contributors to inflammation and colitis-associated colon cancer (CAC). In the present study, we analyzed the impact of TLR4, the receptor for Gram-negative bacteria derived lipopolysaccharides, on intestinal inflammation and tumorigenesis in a murine model of CAC. During the inflammatory phases of CAC development, we observed a strong upregulation of Tlr4 expression in colonic tissues. Blocking of TLR4 signaling by a small-molecule-specific inhibitor during the inflammatory phases of CAC strongly diminished the development and progression of colonic tumors, which was accompanied by decreased numbers of infiltrating macrophages and reduced colonic pro-inflammatory cytokine levels compared to CAC control mice. Interestingly, inhibiting bacterial signaling by antibiotic treatment during the inflammatory phases of CAC also protected mice from severe intestinal inflammation and almost completely prevented tumor growth. Nevertheless, application of antibiotics involved rapid and severe body weight loss and might have unwanted side effects. Our results indicate that bacterial activation of TLR4 on innate immune cells in the colon triggers inflammation and promotes tumor growth. Thus, the inhibition of the TLR4 signaling during intestinal inflammation might be a novel approach to impede CAC development.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Pellino 3 promotes the colitis-associated colorectal cancer through suppression of IRF4-mediated negative regulation of TLR4 signalling
    Kim, Young-Mi
    Kim, Hye-Youn
    Ha Thi, Huyen Trang
    Kim, Jooyoung
    Lee, Young Jae
    Kim, Seong-Jin
    Hong, Suntaek
    MOLECULAR ONCOLOGY, 2023, 17 (11) : 2380 - 2395
  • [42] Fragmented Sleep Accelerates Tumor Growth and Progression through Recruitment of Tumor-Associated Macrophages and TLR4 Signaling
    Hakim, Fahed
    Wang, Yang
    Zhang, Shelley X. L.
    Zheng, Jiamao
    Yolcu, Esma S.
    Carreras, Alba
    Khalyfa, Abdelnaby
    Shirwan, Haval
    Almendros, Isaac
    Gozal, David
    CANCER RESEARCH, 2014, 74 (05) : 1329 - 1337
  • [43] Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice
    Cho, Soo-Jeong
    Kim, Joo Sung
    Kim, Jung Mogg
    Lee, Jong Yeul
    Jung, Hyun Chae
    Song, In Sung
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (04) : 951 - 957
  • [44] Tumor cell intrinsic TLR4 signaling promotes growth and metastasis in melanoma
    Rogava, M.
    Bald, T.
    Shridhar, N.
    van den Boorn-Konijnenberg, D.
    Schmid-Burgk, J.
    Hornung, V.
    Hoelzel, M.
    Tueting, T.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 (03) : E40 - E40
  • [45] Gegen Qinlian Decoction Attenuates Colitis-Associated Colorectal Cancer via Suppressing TLR4 Signaling Pathway Based on Network Pharmacology and In Vivo/In Vitro Experimental Validation
    Xu, Yaoyao
    Cai, Qiaoyan
    Zhao, Chunyu
    Zhang, Weixiang
    Xu, Xinting
    Lin, Haowei
    Lin, Yuxing
    Chen, Daxin
    Lin, Shan
    Jia, Peizhi
    Wang, Meiling
    Zhang, Ling
    Lin, Wei
    PHARMACEUTICALS, 2025, 18 (01)
  • [46] O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms
    Kargl, Julia
    Haybaeck, Johannes
    Stancic, Angela
    Andersen, Liisa
    Marsche, Gunther
    Heinemann, Akos
    Schicho, Rudolf
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (04): : 449 - 458
  • [47] The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model
    Julia Kargl
    Johannes Haybäck
    Angela A Stančić
    Gunther Marsche
    Ákos Heinemann
    Rudolf Schicho
    BMC Pharmacology and Toxicology, 13 (Suppl 1)
  • [48] ANGIOGENIN REGULATES TUMOR GROWTH IN A MOUSE MODEL OF COLITIS-ASSOCIATED CANCER.
    Luo, J.
    Liu, T.
    Yoo, J.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E216 - E216
  • [49] O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms
    Julia Kargl
    Johannes Haybaeck
    Angela Stančić
    Liisa Andersen
    Gunther Marsche
    Akos Heinemann
    Rudolf Schicho
    Journal of Molecular Medicine, 2013, 91 : 449 - 458
  • [50] RETRACTION: Phytosomal Curcumin Inhibits Tumor Growth in Colitis-Associated Colorectal Cancer
    Marjaneh, R. M.
    Rahmani, F.
    Hassanian, S. M.
    Rezaei, N.
    Hashemzehi, M.
    Bahrami, A.
    Ariakia, F.
    Fiuji, H.
    Sahebkar, A.
    Avan, A.
    Khazaei, M.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2025, 240 (04)